| Dr Amber Wilson, PHARMD | |
|
5269 Calhoun Memorial Hwy, Easley, SC 29640 | |
| (864) 859-7168 | |
| (864) 306-2823 |
| Full Name | Dr Amber Wilson |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 5269 Calhoun Memorial Hwy, Easley, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023367919 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 13147 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Amber Wilson, PHARMD 5269 Calhoun Memorial Hwy, Easley, SC 29640 Ph: (864) 859-7168 | Dr Amber Wilson, PHARMD 5269 Calhoun Memorial Hwy, Easley, SC 29640 Ph: (864) 859-7168 |
News Archive
The Chilean miners who have been trapped for more than two months may emerge with psychological problems say experts as the rescue approached. Rescue teams were set to start hoisting up the first of 33 miners, trapped down around 700 metres, to the surface around midnight on Tuesday (1400 AEDT Wednesday), Mines Minister Laurence Golborne said.
Parents are advised to make sure their children drink milk and eat other calcium-rich foods to build strong bones.
PEPID, the top developer of clinical decision-support information and technology for healthcare professionals, has announced a partnership with the American Hospital Formulary Service, the premier provider of drug information. This partnership will put the AFHS Essentials drug information in electronic format, delivered on any mobile device or within any EMR system.
A University of Pennsylvania-developed personalized immunotherapy has been awarded the U.S. Food and Drug Administration's Breakthrough Therapy designation for the treatment of relapsed and refractory adult and pediatric acute lymphoblastic leukemia (ALL).
A new compound that targets anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer is well-tolerated by patients and is already showing early signs of activity, including in patients who no longer respond to crizotinib-the only approved ALK inhibitor. Results of this Novartis-sponsored sudy will be presented by a researcher from Fox Chase Cancer Center during the 2012 Annual Meeting of the American Society of Clinical Oncology on Sunday, June 3.
› Verified 4 days ago
Miss Leslie Ann Martin, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5991 Calhoun Memorial Hwy, Easley, SC 29640 Phone: 864-306-3380 | |
Dr. Meghan Jeanne Dopart, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 410 Pelzer Hwy, Easley, SC 29642 Phone: 864-855-6856 | |
Heather Lilley, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5251 Calhoun Memorial Hwy, Easley, SC 29642 Phone: 864-855-9790 Fax: 864-859-9779 | |
Alicia M Davenport, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5155 Calhoun Memorial Hwy, Easley, SC 29640 Phone: 864-855-2390 Fax: 864-855-1789 | |
Mr. Peter V Varvatsis, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 Fleetwood Dr, Easley, SC 29640 Phone: 864-442-7200 | |
Ashley Lee Scott, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 410 Pelzer Hwy, Easley, SC 29642 Phone: 864-855-6856 |